According to Abeona Therapeutics 's latest financial reports the company's current revenue (TTM) is $3.5 M. In 2022 the company made a revenue of $1.41 M a decrease over the years 2021 revenue that were of $3 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.5 M | 147.52% |
2022 | $1.41 M | -52.87% |
2021 | $3 M | -70% |
2020 | $10 M | |
2019 | N/A | -100% |
2018 | $0.38 M | -53.64% |
2017 | $0.83 M | -5.85% |
2016 | $0.88 M | -14.52% |
2015 | $1.04 M | 12.43% |
2014 | $0.92 M | -54.7% |
2013 | $2.04 M | -53.63% |
2012 | $4.4 M | 138.44% |
2011 | $1.84 M | 283.99% |
2010 | $0.48 M | 36.65% |
2009 | $0.35 M | 20.96% |
2008 | $0.29 M | |
2004 | $0.54 M | -57.61% |
2003 | $1.29 M | 12.9% |
2002 | $1.14 M | 372.02% |
2001 | $0.24 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Merck MRK | $60.11 B | 1,717,442.86% | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | $0.61 B | 17,352.23% | ๐ฎ๐ฑ Israel |